NATCO Pharma Q3 FY2023 Investor Presentation

NATCO Pharma Limited is a diversified pharmaceutical company with a strong domestic presence in oncology and a focused approach to complex generics for the US market. The company operates across India, US, and ROW markets with two R&D centers, state-of-the-art manufacturing facilities, and a growing Crop Health Sciences division. As of March 2022, NATCO reported total revenues of INR 20,438 million with approximately 4,800 employees.